Announcement of a US subsidiary of a Japanese life insurance company

January 22, 2018
by Investment in Japan

What’s Happened in Japan

・Protective to Acquire In Force Blocks of Individual Life and Annuity Business.

・Otsuka Pharmaceutical, a Japanese pharmaceutical company, received approval in Japan for the manufacture and sale of new antipsychotic drug Rexulti® Tablets for schizophrenia.


Jump to The Corporate Announcement Page from Following

Dai-ichi Life Holdings’s announcement

Otsuka Holdings’s announcement